KLMab-1: An Anti-human KLRG1 Monoclonal Antibody for Immunocytochemistry [0.03%]
人KLRG1的单克隆抗体KLMab-1免疫细胞化学检测
Masaki Saito,Hiroyuki Suzuki,Teizo Asano et al.
Masaki Saito et al.
Immune checkpoint molecules have received attention as targets of cancer immunotherapy. Killer cell lectin-like receptor subfamily G member 1 (KLRG1) is one of the immune checkpoint molecules expressed in CD4+ T, CD8+ T, and natural killer ...
Epitope Mapping of an Anti-Mouse CXCR6 Monoclonal Antibody (Cx6Mab-1) Using the 2 × Alanine Scanning Method [0.03%]
基于2倍丙氨酸扫描法的抗小鼠CXCR6单克隆抗体(Cx6Mab-1)表位鉴定
Yu Isoda,Tomohiro Tanaka,Hiroyuki Suzuki et al.
Yu Isoda et al.
The CXC chemokine receptor 6 (CXCR6) is a member of the G protein-coupled receptor family that is highly expressed in helper T type 1 cells, cytotoxic T lymphocytes (CTLs), and natural killer cells. CXCR6 plays critical roles in local expan...
Epitope Mapping of the Anti-Human CC Chemokine Receptor Type-2 Monoclonal Antibody (K036C2) [0.03%]
人CC型趋化因子受体2单克隆抗体(K036C2)表位鉴定
Tomohiro Tanaka,Hiroyuki Suzuki,Guanjie Li et al.
Tomohiro Tanaka et al.
CC chemokine receptor type-2 (CCR2) belongs to the G protein-coupled receptors superfamily, and is localized on cell surface of tumor cells and some immune cells, including monocytes and macrophages. CCR2 is a receptor for monocyte chemoatt...
Generation of Rat Monoclonal Antibody for Mouse Nucleolin by Immunization of Ferroptosis-Induced Hepa 1-6 Cells [0.03%]
通过免疫诱导铁死亡的肝癌细胞产生抗鼠核不均一型核糖核蛋白抗体
Chikako Yokoyama,Sho Kobayashi,Yumi Harada et al.
Chikako Yokoyama et al.
Nucleolin is a multifunctional phosphoprotein that is ubiquitously distributed in the nucleus, nucleoplasm, cytoplasm, and cell membrane. The principal functions of nucleolin involve DNA and RNA metabolism, gene transcription and translatio...
Establishment of Neutralizing Monoclonal Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 by the Screening with Exosomes Expressing the Viral Spike Protein [0.03%]
筛选表达病毒刺突蛋白的外体建立抗新型冠状病毒中和单克隆抗体
Chihiro Okada,Etsuko Ikeda-Ishizaka,Chikako Ono et al.
Chihiro Okada et al.
Monoclonal antibodies (mAbs) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes COVID-19, are the important tools both for the diagnosis and therapeutics of this infectious disease. The high-performance antib...
Thomas Kieber-Emmons,Anastas Pashov
Thomas Kieber-Emmons
Production and Characterization of Monoclonal Antibodies Against the VP7 Protein of Epizootic Hemorrhagic Disease Virus [0.03%]
口蹄疫病毒VP7蛋白单克隆抗体的制备及鉴定
Gisella Armillotta,Tiziana Di Febo,Simonetta Ulisse et al.
Gisella Armillotta et al.
Monoclonal antibodies (MAbs) against epizootic hemorrhagic disease virus (EHDV) were produced by immunizing BALB/c mice with rec-VP7-EHDV2; 66 clones producing MAbs able to recognize the VP7-EHDV with a strong reaction were obtained and tes...
Computer-Aided Tools and Resources for Fungal Pathogens: An Application of Reverse Vaccinology for Mucormycosis [0.03%]
计算机辅助工具和资源在真菌病原体中的应用：毛霉病反向疫苗学研究
Anasuya Bhargav,Firdaus Fatima,Pratibha Chaurasia et al.
Anasuya Bhargav et al.
Increasing fungal infections in immunocompromised hosts are a growing concern for global public health. Along with treatments, preventive measures are required. The emergence of reverse vaccinology has opened avenues for using genomic and p...
Melissa T Bu,Long Yuan,Alyssa N Klee et al.
Melissa T Bu et al.
Blockade of the PD-L1/PD-1 pathway has proven to be a broadly effective cancer immunotherapy. FDA-approved therapeutic monoclonal antibodies (mAbs) targeting the pathway have high affinity, blocking capacity, and low antibody effector activ...
Noninferiority of Subcutaneous Versus Intravenous Casirivimab/Imdevimab for Outpatient Treatment of SARS-CoV-2 in a Real-World Setting [0.03%]
在现实世界中接受门诊治疗的SARS-CoV-2患者皮下注射与静脉注射 casirivimab/imdevimab疗效相当：一项真实世界的非劣效性研究
Alex Belote,Sharon Reece,Samantha Robinson et al.
Alex Belote et al.
Monoclonal antibody (mAb) therapy has emerged as one of the mainstay treatment options for SARS-CoV-2. To improve speed of delivery and decrease bedside nursing needs, subcutaneous (SC) delivery of mAbs has been explored as an alternative t...